Peptide Library - Complete Peptide Database

A small molecule that inhibits NNMT enzyme, boosting NAD+ levels and cellular energy. Supports fat loss and metabolic function.

Inhibits nicotinamide N-methyltransferase (NNMT), increasing NAD+ and SAM availability and altering fat metabolism and muscle regeneration pathways.

A synthetic peptide analog of natural AOD-9604 fragment that stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or insulin.

AOD-9604 primarily functions through selective activation of beta-3 adrenergic receptors in adipose tissue, leading to enhanced expression of beta-3-AR RNA in fat cells. It increases lipolytic sensitivity and responsiveness to metabolic stimuli and directly stimulates hormone-sensitive lipase activity. AOD-9604 promotes the breakdown of stored triglycerides into free fatty acids and glycerol, stimulating lipolysis preferentially in obese fat cells. It also inhibits lipogenesis and enhances fat oxidation and energy expenditure. The peptide avoids IGF-1 elevation, has no significant impact on insulin sensitivity or glucose tolerance, and preserves natural hormonal feedback mechanisms.

A tissue-protective peptide derived from erythropoietin. Shows remarkable efficacy for neuropathy, tissue healing, and inflammation reduction without erythropoietic activity.

ARA-290 works by selectively binding to the Innate Repair Receptor (IRR) complex, which consists of CD131 and the EPO receptor. This binding activates tissue-protective signaling pathways without stimulating erythropoiesis, leading to cellular repair and survival, enhanced tissue resilience, neuroprotection, neural repair, anti-inflammatory effects, and vascular protection.

BPC-157 is a peptide comprising 15 amino acids, derived from a naturally occurring protein found in gastric fluid. It is currently under investigation for its diverse regenerative and protective physiological effects.

BPC-157 exerts its biological effects by interacting with various physiological pathways. It stimulates the formation of new blood vessels through boosting vascular endothelial growth factor, and it counteracts the inhibitory effects of 4-hydroxynonenal on growth. The peptide also upregulates numerous growth factor receptors and enhances fibroblast production, which is crucial for collagen synthesis.

A powerful healing combination that synergistically promotes tissue repair, reduces inflammation, and accelerates recovery from injuries.

BPC-157 may promote angiogenesis, nitric oxide production, and collagen formation. TB-500 is thought to help with actin regulation, an essential protein in cell movement and repair. When combined, they may act synergistically to promote faster repair of injured tissues.

A bioregulator peptide targeting lung and respiratory health. Supports bronchial tissue regeneration and respiratory function as part of longevity protocols.

Bronchogen influences DNA transcription pathways, regulating expression of genes like NKX2-1, SCGB1A1, SCGB3A2, FOXA1, and FOXA2. It may bind deoxyribooligonucleotides containing CNG sequences (targets for cytosine DNA methylation), potentially affecting gene regulation.

Cagrilintide is a synthetic peptide that functions as an agonist for both amylin and calcitonin receptors and is under investigation for its role in weight management and metabolic regulation. It is designed to mimic natural hormones involved in satiety and blood sugar control.

Cagrilintide functions as a dual agonist on amylin and calcitonin receptors, which are crucial for regulating satiety and metabolic processes. By activating these receptors, the peptide signals fullness to the brain, reduces the rate at which the stomach empties, and inhibits the release of glucagon after meals, thereby contributing to lower blood glucose levels and reduced caloric intake.

A cardiovascular bioregulator peptide that supports heart tissue health and function. Used in longevity protocols for cardiac optimization.

Cardiogen is a synthetic tetrapeptide that modulates fibroblast activity (essential for tissue repair and scar formation), promotes synthesis of extracellular matrix components like collagen, and stimulates cardiomyocyte proliferation.

A bioregulator peptide for joint and cartilage health. Supports joint tissue regeneration and reduces age-related cartilage degradation.

Cartalax (tripeptide AED, alanine-glutamate-aspartate) is described as a tissue-targeted ultrashort peptide that may influence gene expression, cell renewal, and local signaling pathways involved in cartilage structure, matrix proteins, and joint resilience, potentially via direct interactions with chromatin components or DNA.

A mixture of neuropeptides that supports brain function, neuroplasticity, and cognitive recovery. Used for neurodegenerative conditions.

Cerebrolysin is a low molecular weight peptide preparation that crosses the blood-brain barrier. It acts as an analogue of endogenous neurotrophic factors, promoting neurogenic and neuroprotective activity. It may interact with adenosine A1 and GABAb receptors and has immunomodulatory effects, reducing microglial activation and LPS-induced interleukin-1β release. In Alzheimer's disease models, it reduces phosphorylation of amyloid precursor protein (APP) by modulating kinase proteins.

A respiratory bioregulator peptide supporting bronchial mucosa and lung function. Part of comprehensive respiratory health protocols.

Chonluten is classified as a potential gene expression peptide. It influences gene expression related to lung repair and regeneration, helping restore normal lung function. It may also modulate genes by interacting with DNA at promoter, suppressor, and other control regions.

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue (GHS) originally developed for treating obesity in HIV/AIDS patients. It is now primarily researched for its potential in addressing growth hormone deficiency, enhancing sleep quality, and its anti-aging properties.

CJC-1295 acts by binding to specific receptors within the pituitary gland, thereby promoting the natural release of both growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Its structure, specifically with the inclusion of Drug Affinity Complex (DAC), allows for a prolonged interaction with plasma proteins, leading to an extended half-life and sustained stimulatory effect on GH and IGF-1 secretion.

A brain bioregulator peptide supporting cortical function and cognitive health. Used in neurological longevity protocols.

Cortagen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Pro, AEDP) developed by Vladimir Khavinson. It is proposed to act through tissue-preferential gene-expression effects in the brain cortex via chromatin remodeling and modulation of transcription, supporting neuroprotection and peripheral nerve regeneration.

A synthetic neuropeptide that promotes sleep onset and maintenance. Derived from hypothalamic sleep-inducing factor.

DSIP promotes sleep by increasing delta rhythm activity in the EEG. It is normally synthesized in the hypothalamus and targets multiple sites including some within the brainstem. The exact mechanisms of its sleep-promoting effects remain unknown.

A potent nootropic peptide derived from BDNF that enhances memory, learning, and cognitive function. Crosses the blood-brain barrier effectively.

Dihexa binds with high affinity to hepatocyte growth factor (HGF) and promotes c-Met signaling and HGF-dependent cellular activity. Activation of c-Met can stimulate neurogenesis and protect against tissue insults in many cell types including neurons. These activities are linked to improved cognitive function and increased dendritic arborization, spinogenesis, and synaptogenesis.

A synthetic tetrapeptide that upregulates telomerase activity and elongates telomeres. Studied for life extension, anti-aging, and disease prevention.

Epitalon can activate telomerase and lengthen telomeres in human cells, extending their replicative lifespan beyond the Hayflick limit. It may also remodel the epigenome by binding to promoter regions, enhance DNA repair, boost antioxidant enzymes through Nrf2 activation, preserve mitochondrial integrity, rebalance T-cell ratios, and stimulate melatonin synthesis while re-entraining clock genes.

Epithalon is a synthetic tetrapeptide that modulates telomerase activity to support cellular longevity and overall systemic health. It is derived from the naturally occurring polypeptide epithalamin, found in the pineal gland.

Epithalon functions by upregulating telomerase activity, an enzyme crucial for maintaining telomere length. This action aids in preserving genomic integrity and cellular functionality over time. Additionally, it influences gene expression and protein synthesis, impacting various physiological processes including melatonin production and antioxidant defenses.

A myostatin-binding protein that promotes muscle growth by inhibiting myostatin's limiting effects on muscle development.

Follistatin blocks the action of activins, myostatin, GDF-11, and follicle-stimulating hormone (FSH). Its effects on muscle growth are primarily due to myostatin inhibition. Follistatin increases in muscle tissue in response to damage and promotes cell growth throughout the body.

A senolytic peptide that targets and eliminates senescent cells. Studied for anti-aging and age-related disease prevention.

FOXO4-DRI is a D-retro-inverso peptide that disrupts the FOXO4-p53 interaction in senescent cells, freeing p53 to drive apoptosis selectively in senescent cells (senolytic action) while sparing healthy cells. It has been shown to reduce endothelial cell senescence via the p53 signaling pathway.

Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone that promotes fat metabolism. It has shown promise in research for reducing blood sugar and aiding cartilage regeneration.

This peptide mimics the lipolytic action of growth hormone by increasing energy expenditure and fat oxidation, without affecting blood glucose levels or insulin sensitivity. It also appears to stimulate myoblast generation, which is integral to muscle tissue repair.

GHK-Cu is a naturally occurring copper-binding peptide found in human plasma, saliva, and urine. It is recognized for its regenerative and protective qualities across various biological systems.

GHK-Cu exerts its effects by modulating the expression of over 4,000 genes, influencing cellular pathways involved in tissue repair, inflammation, and antioxidant responses. Its copper-binding capacity is crucial, as copper is essential for numerous physiological processes, including enzymatic reactions and connective tissue formation. The peptide encourages the synthesis and breakdown of collagen and glycosaminoglycans, key components of extracellular matrix remodeling.

A growth hormone releasing peptide that stimulates natural GH secretion. Works synergistically with GHRH analogues for enhanced growth hormone release.

GHRP-2 (pralmorelin) is a synthetic hexapeptide agonist of the ghrelin receptor (GHS-R1a). It stimulates pulsatile growth hormone release from the anterior pituitary and can transiently elevate cortisol and prolactin.

A potent growth hormone secretagogue that stimulates the pituitary gland. Increases appetite and GH levels with potential effects on body composition.

GHRP-6 is a synthetic hexapeptide ghrelin-receptor (GHS-R1a) agonist that stimulates pulsatile GH release from the anterior pituitary and increases appetite via central ghrelin signaling.

A healing and beauty peptide combination. GHK-Cu provides skin regeneration and collagen synthesis while BPC-157 and TB-500 accelerate tissue repair.

GLOW Peptide Therapy combines BPC-157, TB-500, and GHK-Cu. GHK-Cu supports wound healing, improves skin elasticity, and stimulates collagen and glycosaminoglycan production. BPC-157 supports tissue repair and inflammation modulation, promoting angiogenesis. TB-500 is involved in cell migration, tissue regeneration, wound healing, and anti-inflammatory pathways.

Hexarelin is a synthetic ghrelin analog that stimulates growth hormone production, primarily studied for its effects on body composition and recovery. Research indicates additional benefits like neuroprotection and cardioprotection.

Hexarelin functions as a growth hormone secretagogue by mimicking the endogenous hormone ghrelin. It achieves its effects by binding to the ghrelin/growth hormone secretagogue receptor (GHS-R), thereby stimulating the pituitary gland to release growth hormone. While primarily influencing growth hormone, hexarelin also exhibits a dose-dependent impact on the release of prolactin, adrenocorticotropic hormone, and cortisol.

A mitochondria-derived peptide with cytoprotective and metabolic regulatory properties. Supports cellular stress response and longevity.

Humanin is a mitochondrial-derived peptide with cytoprotective properties. It influences metabolism, promotes insulin sensitivity, and modulates JAK2, STAT3, MAPK, and JNK signaling. Cytoprotective effects are largely mediated through the humanin heterotrimeric receptor complex (CNTFRα, WSX-1, gp130).

An extended form of IGF-1 with increased half-life and potency. Promotes muscle growth and recovery with enhanced anabolic effects.

IGF-1 LR3 functions by binding to cell receptors in muscle tissue, triggering a cascade of biological responses. Its modified structure allows it to bypass typical protein binding. It enhances glucose transport, activates protein synthesis, stimulates cell communication pathways for growth, and regulates metabolism.

Ipamorelin is a synthetic protein fragment that stimulates the body's natural growth hormone release by mimicking ghrelin. It is being researched for its potential to improve body composition and aid in tissue repair.

Ipamorelin functions as a selective growth hormone secretagogue and an agonist of the ghrelin receptor. It initiates growth hormone production by mimicking the action of ghrelin, stimulating somatocrinin release, and inhibiting somatostatin. This leads to a targeted increase in growth hormone without significantly affecting other hormones.

A powerful synergistic combination of growth hormone secretagogues. Ipamorelin provides selective GH release while CJC-1295 extends GH pulse duration for enhanced fat loss and recovery.

CJC-1295 (no DAC) is a GHRH analogue that stimulates the pituitary to release endogenous GH and increases IGF-1. Ipamorelin is a GHRP. When administered together they have synergistic effects on GH with minimal impact on ghrelin, prolactin, ACTH, or cortisol.

A hypothalamic neuropeptide hormone that triggers puberty onset and regulates reproductive function. Key regulator of GnRH release.

Kisspeptin-10 is a neuropeptide product of the KISS1 gene, consisting of a conserved C-terminal 10-amino-acid sequence. It binds the G-protein-coupled receptor GPR54, directly stimulating the hypothalamus to release GnRH at the top of the HPG axis.

An advanced healing and recovery blend combining tissue repair peptides with anti-inflammatory KPV for comprehensive recovery support.

KLOW is a synergistic peptide blend addressing inflammation, tissue damage, impaired healing, and cellular dysfunction by combining GHK-Cu, KPV, BPC-157, and TB-500.

An anti-inflammatory tripeptide derived from alpha-MSH. Potent immunomodulatory properties help reduce inflammation and support gut health.

KPV inhibits activation of NF-κB, a master transcription factor regulating immune responses and inflammation. By suppressing NF-κB it reduces production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.

An amino acid that transports fatty acids into mitochondria for energy production. Supports fat burning, exercise performance, and muscle recovery.

L-carnitine transports long-chain fatty acids into the mitochondria where they are oxidized to produce ATP. It also helps move toxic compounds out of the mitochondria.

Liraglutide is a synthetic glucagon-like peptide-1 receptor agonist that aids in blood sugar regulation. It is approved for managing type 2 diabetes and obesity.

Liraglutide functions by acting as an agonist at glucagon-like peptide-1 receptors (GLP-1R) throughout the body. In the pancreas, it boosts insulin secretion and curtails glucagon release, contributing to blood sugar control. It also slows gastric emptying, promotes satiety via central nervous system activation, and may reduce triglyceride release from adipose tissue, thereby increasing insulin sensitivity.

A liver bioregulator peptide supporting hepatic tissue regeneration and function. Essential for metabolic and detoxification health.

Livagen is an ultra-short peptide that penetrates cell nuclei and interacts directly with DNA to restore youthful patterns of gene expression. It targets liver and immune-system tissues by influencing DNA structure and gene expression.

A naturally occurring antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi. Part of the innate immune system.

LL-37 (cathelicidin) is an endogenous antimicrobial peptide that disrupts bacterial, fungal, and viral membranes and modulates innate immunity, chemotaxis, and wound healing.

Mazdutide is a synthetic peptide analog that mimics the activity of oxyntomodulin, a naturally occurring gut hormone. It is currently undergoing extensive research for its potential in managing type 2 diabetes and promoting weight loss.

Mazdutide functions as a dual agonist, activating both glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors. This dual action contributes to its metabolic effects, including appetite suppression, enhanced insulin secretion, and increased energy expenditure. It also plays a role in delaying gastric emptying and promoting the conversion of white fat to beige fat.

An alpha-MSH analogue that stimulates melanogenesis for skin darkening. Provides photoprotection without UV exposure.

Melanotan 1 is an analog of alpha-melanocyte-stimulating hormone (α-MSH) that induces skin tanning by stimulating melanogenesis, leading to increased production and secretion of melanin and providing a protective mechanism against UV.

Melanotan I is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH), primarily investigated for its role in stimulating melanin production and skin pigmentation. It is also being explored for various therapeutic applications beyond tanning.

Melanotan I functions as an agonist at melanocortin receptors, primarily targeting MC1R. This binding action initiates increased production of melanin, the pigment responsible for skin, hair, and eye color. It is structurally similar to α-MSH but exhibits enhanced potency and stability.

Melanotan II is a synthetic alpha-melanocyte-stimulating hormone (α-MSH) analog, initially developed for its tanning properties, which also notably influences sexual function and appetite regulation.

Melanotan II acts as an agonist at melanocortin receptors, primarily MC1, MC3, and MC4. Activation of MC1 receptors leads to increased melanin production for skin pigmentation. Stimulation of MC4 receptors influences sexual arousal and erectile function, while MC3 receptor engagement impacts appetite and energy balance.

MK-677 is an orally active, non-peptide compound that functions as a ghrelin receptor agonist and growth hormone secretagogue, leading to increased secretion of growth hormone and insulin-like growth factor 1, potentially enhancing body composition, sleep quality, and bone density.

This compound mimics the action of ghrelin, binding to growth hormone secretagogue receptors (GHS-R) and thereby stimulating the pituitary gland to release growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Unlike many other compounds, it achieves this without significantly elevating cortisol levels. Its mechanism specifically avoids interfering with the body's natural negative feedback loops for GH regulation. Importantly, this secretagogue is not a somatostatin analog.

MOTS-c is a mitochondrial-derived peptide involved in metabolic regulation. It has shown therapeutic potential for metabolic disorders, cardiovascular disease, and enhancing athletic performance.

MOTS-c modulates metabolic function by translocating to the nucleus under metabolic stress and activating AMPK. It influences adaptive gene expression to regulate energy homeostasis.

N-Acetyl Selank Amidate is a modified version of the nootropic peptide Selank, engineered for enhanced stability and improved blood-brain barrier permeability. It exhibits anxiolytic and cognitive-enhancing properties similar to its parent compound.

This peptide crosses the blood-brain barrier and influences the central nervous system by modulating levels of brain-derived neurotrophic factor (BDNF), as well as interacting with opioid, serotonergic, and GABAergic signaling pathways. This activity contributes to its anxiolytic, stress-reducing, and nootropic effects.

N-Acetyl Semax Amidate is a modified version of the Semax peptide, engineered for improved stability and enhanced potency. It is currently under investigation for a variety of nootropic and neuroprotective effects, including memory improvement and mood regulation.

N-Acetyl Semax Amidate is believed to function similarly to Semax, by stimulating neurotrophic factors within the central nervous system. It also interacts with signaling pathways involving enkephalin, serotonin, and dopamine, which are key neurotransmitters in mood, stress, and reward circuits. This peptide is thought to enhance the production of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), both of which are crucial for neuronal growth and regeneration. Its structural modifications, particularly N-terminal acetylation and C-terminal amidation, contribute to increased resistance against enzymatic degradation, leading to prolonged activity within the body.

A coenzyme essential for cellular energy production and DNA repair. Declines with age, making supplementation relevant for longevity.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to energy metabolism and cellular maintenance. It participates in redox reactions that drive ATP production, supports key metabolic enzymes, and is consumed by DNA-repair and sirtuin enzymes.

A bioregulator peptide targeting liver and stomach health. Supports digestive function and hepatic regeneration.

Ovagen is a tripeptide bioregulator (Glu-Asp-Leu) that targets the liver and gastrointestinal tract at the genetic level, influencing gene expression and DNA transcription. It is described as preferentially binding AT-rich stretches of mammalian DNA and modulating proteins related to proliferation and cellular aging.

A hypothalamic neuropeptide involved in social bonding, reproduction, and stress regulation. Known as the "love hormone."

Oxytocin is a neuropeptide implicated in social behavior that also exerts antinociceptive (pain-reducing) effects. Subcutaneous oxytocin has been shown to reduce heat-pain intensity and unpleasantness ratings locally on the injected arm, suggesting a peripheral mechanism in addition to its central actions.

A synthetic CNTF-derived peptide that promotes neurogenesis and cognitive function. Studied for neurodegenerative disease and brain health.

P21 (P021, Peptide 6) is a synthetic tetrapeptide mimetic of ciliary neurotrophic factor (CNTF). It is proposed to act primarily in the CNS, particularly the dentate gyrus, mimicking CNTF effects while avoiding the adverse effects of full-length CNTF.

A pancreatic bioregulator peptide supporting pancreatic tissue health and metabolic function. Important for blood sugar regulation.

Pancragen (KEDW tetrapeptide) is a bioregulator proposed to penetrate cellular membranes and interact with the nucleus and nucleolus, influencing gene transcription involved in pancreatic cell differentiation and potentially affecting gene methylation. It has been reported to decrease pro-apoptotic p53 and increase anti-apoptotic Mcl1, suggesting anti-apoptotic potential.

A BDNF-derived nootropic peptide that enhances cognitive function and memory. Promotes neuroplasticity and brain health.

PE-22-28 selectively blocks TREK-1 potassium channels, enhancing neuronal depolarization, synaptic transmission, and firing. It promotes serotonin signaling and upregulates BDNF, supporting neuroplasticity and neurogenesis, and modulates the HPA axis to reduce stress-induced damage.

A short peptide bioregulator that supports pineal gland function and melatonin production. Part of the Khavinson peptide family.

Pinealon is a tripeptide that demonstrates selective uptake by pineal-gland tissue. Research suggests it restores pineal function and melatonin production, supports circadian entrainment, inhibits reactive oxygen species (ROS) buildup, blocks ERK 1/2 activation, and improves neuronal membrane stability and survival. It has shown protective effects against prenatal hyperhomocysteinemia in rat offspring.

A prostate bioregulator peptide supporting male reproductive health and prostate tissue function. Part of men's health optimization.

Prostamax is a synthetic tetrapeptide (Lys-Glu-Asp-Pro, KEDP) derived from prostate peptide research. It may modulate gene expression via interactions with chromatin and histones, potentially activating previously repressed genes. In prostatic gland tissue cultures it has been reported to facilitate repair, reduce inflammation, and oppose sclerotic and atrophic changes.

PT-141, also known as bremelanotide, is a synthetic peptide derived from melanocyte-stimulating hormone. It is primarily recognized for its role in modulating sexual function and desire in both men and women.

PT-141 functions as a melanocortin receptor agonist, particularly targeting MC4R in the central nervous system. This activation leads to an increase in dopamine release, which is associated with heightened sexual desire and arousal.

Retatrutide is a synthetic peptide that functions as an incretin mimetic, specifically a triple agonist targeting GIP, GLP-1, and glucagon receptors. It is under investigation for its efficacy in managing metabolic conditions such as obesity and type 2 diabetes.

Retatrutide acts as a triple agonist, activating glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. This multifaceted action contributes to appetite suppression, increased energy expenditure, enhanced insulin secretion, and improved glucose metabolism. The GIP and GLP-1 agonism primarily reduces hunger and slows gastric emptying, while glucagon receptor activation influences metabolic rate and fat breakdown.

Selank is a synthetic peptide derived from tuftsin, recognized for its anxiolytic and cognitive-enhancing properties. It is extensively researched for its influence on mental well-being and cognitive function.

Selank primarily acts on the central nervous system by modulating the activity of neurotransmitters such as GABA, serotonin, and dopamine. It alters the expression of GABA receptor genes, increasing their affinity for GABA, which helps reduce neuronal excitability. Additionally, Selank protects endogenous enkephalins from degradation, contributing to its anxiety-reducing and pain-modulating effects.

Semaglutide is a synthetic polypeptide that mimics the action of the naturally occurring hormone GLP-1, playing a crucial role in metabolic regulation. It is utilized in managing both type 2 diabetes and obesity.

Semaglutide acts as a GLP-1 receptor agonist, enhancing glucose-dependent insulin secretion and suppressing glucagon release. This mechanism leads to reduced blood glucose levels, slowed gastric emptying, and increased satiety, which collectively contribute to its therapeutic effects on diabetes and obesity.

Semax is a synthetic peptide developed in Russia with documented nootropic and neuroprotective capabilities. It primarily influences brain function and has applications in cognitive enhancement and neuroprotection.

Semax functions by stimulating the production of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) within the central nervous system. Additionally, it interacts with the signaling pathways of dopamine, serotonin, and enkephalins. These combined actions contribute to its effects on neurogenesis, neuroprotection, and cognitive processes.

Sermorelin is a synthetic peptide that functions as a growth hormone-releasing hormone analog, stimulating the body's natural production and release of growth hormone. It was initially developed for treating growth hormone deficiency in both children and adults.

Sermorelin acts as an analog to growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on the anterior pituitary gland, prompting the somatotropic cells to synthesize and release endogenous growth hormone. This mechanism differs from direct growth hormone administration, as sermorelin encourages the body's own regulatory processes.

A mitochondria-targeting antioxidant peptide that protects against oxidative stress. Studied for age-related diseases and cellular energy.

SS-31 (elamipretide) targets the inner mitochondrial membrane and interacts with cardiolipin, stabilizing the respiratory chain and improving mitochondrial bioenergetics.

TB-500 is a synthetic form of the naturally occurring peptide thymosin beta-4, currently under investigation for its regenerative and wound-healing properties. Research indicates its potential in tissue repair and recovery processes across various bodily systems.

TB-500 primarily functions by upregulating actin, a crucial protein for cellular structure and movement, while concurrently inhibiting its polymerization. It also stimulates the formation of new blood vessels, a process known as angiogenesis, likely through effects on the Notch signaling pathway, thereby facilitating repair in damaged tissues.

Tesamorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), stimulating the body's natural production of growth hormone. It is primarily recognized for its role in reducing excess abdominal fat in individuals with HIV-associated lipodystrophy, and is also being investigated for its potential cognitive and regenerative properties.

Tesamorelin acts as an analog of growth hormone-releasing hormone (GHRH), binding to receptors on the anterior pituitary gland. This interaction stimulates the somatotropic cells within the pituitary to synthesize and secrete endogenous growth hormone (GH). The peptide's unique structure, including a trans-3-hexenoic acid group, enhances its stability and prolongs its half-life compared to natural GHRH.

A potent growth hormone secretagogue combination. Tesamorelin provides sustained GHRH stimulation while Ipamorelin adds selective GH pulsatility for optimal fat loss and muscle building.

Tesamorelin is a GHRH analog that drives endogenous GH release with strong effects on metabolism and visceral fat. Ipamorelin is a selective GHRP that adds a clean pulse of GH secretion. Combined, they support natural pulsatile GH release.

A serotonin-norepinephrine-dopamine reuptake inhibitor originally studied as an anti-obesity agent. Promotes weight loss through appetite suppression.

Tesofensine is a triple monoamine reuptake inhibitor (serotonin, noradrenaline, dopamine - SNDRI) that modulates appetite, energy expenditure, and motivation.

A bioregulator peptide supporting male hormonal health and testicular function. Used in male optimization and longevity protocols.

Testagen is a synthetic tetrapeptide (Lys-Glu-Asp-Gly, KEDG) proposed as an anterior-pituitary-derived bioregulator that modulates endocrine function, particularly the pituitary-gonadal axis, via a transcriptional 'nudge' rather than sustained pharmacological action.

An immune bioregulator peptide supporting thymus function and immune system health. Essential for immune longevity.

Thymagen is a thymus-derived peptide that stimulates and modulates immune function, enhancing T-cell activity. It modulates T-cell differentiation and nucleic-acid synthesis via thymic-receptor signaling and has reported effects on cAMP and cGMP in lymphocytes.

A thymic peptide bioregulator that supports immune system function and longevity. Helps restore thymic function and modulate immune responses as part of anti-aging protocols.

Thymalin is a polypeptide extract from calf thymus that supports cellular immunity by promoting T-cell maturation and differentiation, restoring T-helper / T-suppressor balance, and modulating cytokine production.

Thymosin Alpha-1 is a peptide derived from the thymus gland that plays a crucial role in regulating immune responses, particularly those involving T-cells. It is a focus of research across various medical fields due to its potent immunomodulatory properties.

Thymosin Alpha-1 operates by augmenting T-cell mediated immune responses. It stimulates the differentiation and maturation of T-cells, activates natural killer cells, and promotes the function of dendritic cells. Additionally, it triggers the release of pro-inflammatory cytokines, which are essential for a robust immune reaction.

Tirzepatide is a synthetic peptide that functions as a dual agonist for GIP and GLP-1 receptors. It is recognized for its role in enhancing glycemic control and promoting weight reduction.

This peptide acts as a dual agonist on both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action leads to a synergistic effect, promoting improved insulin secretion from pancreatic beta cells and exhibiting glucagonostatic properties. The biased agonism at the GLP-1 receptor, favoring cAMP signaling, contributes to its enhanced efficacy.

A synergistic combination targeting mitochondrial function, cellular energy, and fat metabolism. Combines NAD+ precursor with mitochondrial peptide and NNMT inhibitor for comprehensive metabolic support.

Combination blend of NAD+ (sirtuin/PARP cofactor supporting cellular energy), MOTS-c (mitochondrial-derived peptide activating AMPK and improving glucose homeostasis), and 5-Amino-1MQ (NNMT inhibitor preserving NAD+ and methyl donors). The three converge on mitochondrial function, cellular energy, and metabolic regulation.

A bioregulator peptide for bladder and prostate health. Supports urinary function and prostate tissue regeneration.

Synthetic dipeptide (Glu-Asp / ED) Khavinson bioregulator proposed to interact with ATTT DNA motifs and modulate gene expression in bladder and prostate tissues.

A vascular bioregulator peptide supporting blood vessel health and circulation. Important for cardiovascular longevity.

Synthetic tripeptide (Lys-Glu-Asp / KED) proposed to bind regulatory DNA regions and modulate gene expression in vascular endothelial and immune tissues; classified as a Khavinson short-chain bioregulator.

A thymus bioregulator peptide with anti-inflammatory properties. Supports immune function and reduces systemic inflammation.

Synthetic dipeptide (Lys-Glu / KE) Khavinson bioregulator proposed to act via direct peptide-DNA binding and epigenetic regulation of immune-cell gene expression, mimicking thymulin activity.

A vasoactive peptide with broad physiological effects including vasodilation, immune modulation, and neuroprotection.

28-amino-acid neuropeptide of the secretin/glucagon family; binds VPAC1 and VPAC2 G-protein-coupled receptors, raising cAMP. Produces vasodilation, smooth muscle relaxation, immune modulation, and anti-inflammatory effects.